141 related articles for article (PubMed ID: 1079770)
1. Potentiation and arming of lymphocyte mediated immunity by sera from melanoma patients.
Vanwijck R; Bouillenne C; Malek-Mansour S
Eur J Cancer (1965); 1975 Apr; 11(4):267-76. PubMed ID: 1079770
[No Abstract] [Full Text] [Related]
2. Immunology and cutaneous malignant melanoma.
Sober AJ
Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
[No Abstract] [Full Text] [Related]
3. Non-specific and specific immunotherapy in patients with melanoma.
Seigler HF; Shingleton WW; Metzgar RS; Buckley CE; Bergoc PM; Miller DS; Fetter BF; Phaup MB
Surgery; 1972 Jul; 72(1):162-74. PubMed ID: 4555924
[No Abstract] [Full Text] [Related]
4. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
[TBL] [Abstract][Full Text] [Related]
5. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
6. [Immunological aspects in malignant melanoma].
Macher E
Arch Dermatol Forsch; 1972; 244():234-9. PubMed ID: 4675197
[No Abstract] [Full Text] [Related]
7. Immunotherapy for melanoma.
Vaisrub S
JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440
[No Abstract] [Full Text] [Related]
8. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME
Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739
[TBL] [Abstract][Full Text] [Related]
9. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
10. Current concepts of the biology of human cutaneous malignant melanoma.
Clark WH; Mastrangelo MJ; Ainsworth AM; Berd D; Bellet RE; Bernardino EA
Adv Cancer Res; 1977; 24():267-338. PubMed ID: 322460
[No Abstract] [Full Text] [Related]
11. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.
Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM
Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574
[No Abstract] [Full Text] [Related]
12. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
13. The immune response in human malignant melanoma.
Mackie RM
Clin Exp Dermatol; 1976 Mar; 1(1):23-8. PubMed ID: 773575
[No Abstract] [Full Text] [Related]
14. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
15. Intralesional BCG in the treatment of metastatic malignant melanoma.
Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
[TBL] [Abstract][Full Text] [Related]
16. [Immunology and melanoma. Theoretical-experimental observations].
Jurado A; Céspedes de Gómez M
Alergia; 1981 Oct; 28(4):145-72. PubMed ID: 7332071
[No Abstract] [Full Text] [Related]
17. Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor.
Maurer H; McIntyre OR; Rueckert F
Am J Surg; 1974 Apr; 127(4):397-403. PubMed ID: 4274502
[No Abstract] [Full Text] [Related]
18. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
19. [Evidence for tumor immunity in human malignant melanoma].
Nagel GA
Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
[No Abstract] [Full Text] [Related]
20. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
